✦ LIBER ✦

Reconsidering the Placebo Response from a Broad Anthropological Perspective

✍ Scribed by Jennifer Jo Thompson; Cheryl Ritenbaugh; Mark Nichter

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 374 KB
Volume: 33
Category: Article
ISSN: 0165-005X
DOI: 10.1007/s11013-008-9122-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A response to BIO 2010: Transforming und

A response to BIO 2010: Transforming undergraduate education for future research biologists, from the perspective of the biochemistry and molecular biology major program at Kenyon College

✍ Joan L. Slonczewski; Rosemary Marusak 📂 Article 📅 2004 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 51 KB 👁 2 views

## Abstract The National Research Council completed a major study of undergraduate biology education, __BIO 2010‐Transforming Undergraduate Education For Future Research Biologists__ (__BIO 2010__), funded by the Howard Hughes Medical Institute and the National Institutes of Health. The __BIO 2010_

Tocilizumab inhibits structural joint da

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

✍ Joel M. Kremer; Ricardo Blanco; Marek Brzosko; Ruben Burgos-Vargas; Anne-Marie H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 3 views

An index of the three core data set pati

An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial

✍ T. Pincus; V. Strand; G. Koch; I. Amara; B. Crawford; F. Wolfe; S. Cohen; D. Fel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 3 views

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa